Center for Scientific Review; Notice of Closed Meeting, 1753 [2019-00972]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 24 / Tuesday, February 5, 2019 / Notices
staff support for executing the mission
of the U.S. Public Health Service
Commissioned Corps: protect, promote,
and advance the health and safety of our
Nation. As America’s uniformed service
of public health professionals, the
Commissioned Corps achieves its
mission through: (1) Rapid and effective
response to public health needs, (2)
Leadership and excellence in public
health practices, and (3) Advancement
of public health science. The Office of
Commissioned Corps Headquarters: (1)
Provides overall management of
Commissioned Corps personnel
including active duty Regular Corps,
Ready Reservists and of those issues and
PHS processes pertinent to retired Corps
officers; (2) Develops, issues,
implements and maintains all personnel
policy issuances and directives related
to Corps operations, personnel, training,
readiness, assignment, deployment,
promotion, and retirement (including
publication of such policy in the
electronic Commissioned Corps
Issuance System (eCCIS)); (3) Manages
the process for disciplinary actions and
decisions involving Corps officers; (4)
Ensures the appropriate exercise of
delegated Commissioned Corps
authorities and responsibilities; (5)
Establishes precepts for appointment,
promotion, assimilation, retirement,
fitness for duty, awards and
commendations, discipline, grievance,
and other such matters; (6) With respect
to Board of Inquiry (BOI) disciplinary
proceedings, ensures documentation of
board proceedings, preparation of
correspondence to applicants and
officers, and timely and accurate advice
and assistance to Board members and
other support as required; (7) Conducts
force planning, including working with
agencies, and advises OSG and ASH on
Commissioned Corps strategic long-term
readiness planning; (8) Maintains
liaison with all other relevant Federal
Services as appropriate, including with
components of the Departments of
Defense and Veterans Affairs; (9)
Coordinates as appropriate to seek
Departmental legal advice, assistance,
and legislative support; (10) Advises the
OSG on mission nature, size, duration
and usage of Regular Corps and Ready
Reserve officers; (11) Serves as a central
point of contact and prepares necessary
communications for all Corps Agency
Liaison Offices; (12) Oversees the
determination of fitness-for-duty and
disability evaluations; and oversees Line
of Duty determinations of the evaluation
and issuance of medical waivers; (13)
Manages and processes compensation
and healthcare claims for members of
the Corps; and administers the Service
VerDate Sep<11>2014
17:22 Feb 04, 2019
Jkt 247001
members’ Group Life Insurance and
Traumatic Serviceman’s Group Life
Insurance Programs; (2 (13)) Serves as
the principal advisor to the SG on
activities and policy related to
preparedness, Corps activation, training,
deployment operations and total force
fitness of the Corps; (14) Leads and
manages the Corps readiness and
response activities to include
establishing, maintaining and ensuring
compliance with force readiness
standards; ensuring that members of the
Corps are trained, equipped and
otherwise prepared to fulfill their public
health and emergency response roles;
and managing the timely, effective and
appropriate response to urgent or
emergency public health care needs;
(15) Conducts after-action assessments
and evaluations for the SG and ASH
pertaining to the use of the Corps for
deployment and other non-routine use
of officers; and (16) Manages and
maintains Commissioned Corps officer
records; and provides oversight and
management of information systems
development, integration, and data
analytics activities in support of the
management of the Commissioned
Corps.
Delegations of Authority. Directives
and orders of the Secretary, Assistant
Secretary for Health, or Surgeon General
and all delegations and re-delegations of
authority previously made to officials
and employees of the affected
organizational components will
continue in them or their successors
pending further re-delegation, provided
they are consistent with this
reorganization. All delegated authorities
associated with or necessary to
administer, operate, and manage
transferred entities affected by this
reorganization are transferred to the
Assistant Secretary for Health and may
be re-delegated.
Alex M. Azar II,
Secretary.
[FR Doc. 2019–00955 Filed 2–4–19; 8:45 am]
BILLING CODE 4150–49–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
1753
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Panel Name:
Early Life Stressors and Alcohol Use
Disorders.
Date: February 21, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Marriott Georgetown,
1221 22nd Street NW, Washington, DC
20037.
Contact Person: Michael Selmanoff, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5164,
MSC 7844, Bethesda, MD 20892, 301–435–
1119, selmanom@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 30, 2019.
Sylvia L. Neal,
Program Analyst. Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–00972 Filed 2–4–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Pathogenic Eukaryotes Study Section.
Date: February 21–22, 2019.
Time: 8:30 a.m. to 5:00 p.m.
E:\FR\FM\05FEN1.SGM
05FEN1
]]>Agencies
[Federal Register Volume 84, Number 24 (Tuesday, February 5, 2019)]
[Notices]
[Page 1753]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00972]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Panel Name: Early Life Stressors and Alcohol Use Disorders.
Date: February 21, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Washington Marriott Georgetown, 1221 22nd Street NW,
Washington, DC 20037.
Contact Person: Michael Selmanoff, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5164, MSC 7844, Bethesda, MD
20892, 301-435-1119, selmanom@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: January 30, 2019.
Sylvia L. Neal,
Program Analyst. Office of Federal Advisory Committee Policy.
[FR Doc. 2019-00972 Filed 2-4-19; 8:45 am]
BILLING CODE 4140-01-P
